Translation, Protein Processing and Degradation
Ribosomes, tRNA charging, initiation to termination, translational control and inhibitors, PTMs, protein targeting and the ubiquitin-proteasome system.
- 23 min
On this page · 18 sections
- Prerequisites
- The Hook: A Ribosome That Works Without Its Proteins
- The Genetic Code
- Aminoacyl-tRNA Synthetases: The Real Translators
- The Ribosome
- The Stages of Translation
- Inhibitors of Protein Synthesis
- Regulation of Translation
- Post-translational Modifications (PTMs)
- Protein Trafficking
- Protein Degradation
- Memory Tricks
- Don’t Confuse
- Common Mistakes
- Practice
- Quick Revision Table
- Key Takeaways
- What’s Next
Prerequisites
- Transcription, RNA Processing and Non-coding RNA — the cap, the poly(A) tail, the EJC and tRNA processing all matter here.
- Protein Structure, Conformation and Stability — folding, chaperones and disulfide bonds.
- Bioenergetics and Metabolism — ATP and GTP as currencies; the cost of protein synthesis.
The Hook: A Ribosome That Works Without Its Proteins
The Genetic Code
- Triplet, non-overlapping, commaless, degenerate, nearly universal. 64 codons: 61 sense codons, 3 stops (UAA ochre, UAG amber, UGA opal).
- AUG codes Met and starts translation; bacteria occasionally use GUG or UUG as start codons, which are still read as fMet at the start.
- Exceptions: in vertebrate mitochondria UGA = Trp, AUA = Met, and AGA/AGG are stops; in some ciliates UAA/UAG code Gln.
- Recoding: selenocysteine (Sec, the “21st amino acid”) is inserted at specific UGA codons that have a downstream SECIS element; Sec-tRNASec is first charged with Ser and then converted. Pyrrolysine is inserted at UAG in some archaea and bacteria.
Wobble
Crick’s wobble hypothesis: the first two codon bases pair strictly; the third codon base (paired with the first anticodon base, position 34) can pair loosely.
| Anticodon 5’ base (wobble position) | Pairs with codon 3’ base |
|---|---|
| C | G |
| A | U |
| U | A or G |
| G | C or U |
| I (inosine) | U, C or A |
Consequences: one tRNA can read more than one codon, and fewer than 61 tRNAs are needed; textbooks give a minimum of about 32 tRNAs to read all 61 sense codons (31 elongator + 1 initiator).
Aminoacyl-tRNA Synthetases: The Real Translators
The code is enforced not by the ribosome but by the aminoacyl-tRNA synthetases (aaRS), one per amino acid (typically 20).
$$\text{aa} + \text{ATP} \rightarrow \text{aa-AMP} + \text{PP}_i \qquad \text{aa-AMP} + \text{tRNA} \rightarrow \text{aa-tRNA} + \text{AMP}$$PPi is hydrolysed, so charging costs two high-energy phosphate bonds (ATP → AMP).
| Feature | Class I | Class II |
|---|---|---|
| Fold | Rossmann fold | Antiparallel β-sheet |
| Attaches aa to | 2’-OH of terminal A (then transesterifies to 3') | 3’-OH (except PheRS, which uses 2') |
| Quaternary state | Mostly monomeric | Mostly dimeric |
Proofreading (“double sieve”): IleRS also activates the smaller Val at a low but significant rate, but a separate editing site hydrolyses Val-AMP or Val-tRNAIle; amino acids larger than Ile are excluded by the first sieve. Overall translation error is about 1 per 10⁴ amino acids, far worse than replication, and acceptable because proteins are short-lived and replaceable.
Identity elements of a tRNA are not always the anticodon; for tRNAAla a single G3·U70 base pair in the acceptor stem is a major determinant. And once charged, the ribosome does not check the amino acid: the classic Cys-tRNACys → Ala-tRNACys experiment (Raney nickel desulfuration) showed that the altered tRNA put Ala into Cys positions. The adaptor, not the amino acid, is read.
The Ribosome
| Bacterial (70S) | Eukaryotic cytosolic (80S) | |
|---|---|---|
| Small subunit | 30S: 16S rRNA + proteins | 40S: 18S rRNA + proteins |
| Large subunit | 50S: 23S + 5S rRNA + proteins | 60S: 28S + 5.8S + 5S rRNA + proteins |
Sedimentation coefficients are not additive (30S + 50S = 70S), because S depends on shape as well as mass.
Functional centres
- Decoding centre (small subunit, 16S rRNA): conserved adenines (A1492, A1493 in E. coli) monitor the minor groove of the codon–anticodon helix.
- Peptidyl transferase centre (large subunit, 23S rRNA): catalyses peptide bond formation.
- Three tRNA sites: A (aminoacyl), P (peptidyl), E (exit).
- A polypeptide exit tunnel runs through the large subunit; macrolides bind in it.
The Stages of Translation
Initiation in bacteria
- IF3 binds the 30S subunit and keeps it apart from 50S; IF1 occupies the A site.
- The mRNA binds through the Shine–Dalgarno sequence (purine-rich, around AGGAGG), which pairs with the anti-SD sequence at the 3’ end of 16S rRNA, positioning the start codon in the P site. This is why a bacterial mRNA can have several start sites (polycistronic mRNAs).
- IF2·GTP brings fMet-tRNAfMet directly to the P site. The formyl group comes from N¹⁰-formyltetrahydrofolate (methionyl-tRNA formyltransferase); it blocks the amino group so fMet can only be N-terminal.
- 50S joins, IF2 hydrolyses GTP, IFs leave → 70S initiation complex.
The formyl group is usually removed by a deformylase, and Met often by methionine aminopeptidase (when the second residue is small).
Initiation in eukaryotes (cap-dependent scanning)
graph TD
A["eIF2·GTP·Met-tRNAi
(ternary complex)"] --> B["43S pre-initiation complex
40S + ternary complex +
eIF1, eIF1A, eIF3, eIF5"]
C["eIF4F on the cap
4E binds cap, 4G scaffold,
4A helicase; PABP-4G loop"] --> D["48S complex: 43S
loaded at the 5' end"]
B --> D
D --> E["Scanning 5' → 3' (ATP)
until AUG in good
Kozak context"]
E --> F["eIF5 triggers eIF2 GTP
hydrolysis; eIF5B·GTP
joins 60S → 80S"]
F --> G["eIF2·GDP recycled
by GEF eIF2B"]- Kozak context: gccRccAUGG — a purine at −3 (A best) and G at +4 are the most important positions.
- No formylation: the initiator Met-tRNAᵢ is not formylated in the cytosol (mitochondria and chloroplasts do use fMet).
- Usually the first AUG is used; weak contexts allow leaky scanning; upstream ORFs (uORFs) and re-initiation regulate some mRNAs.
- IRES (internal ribosome entry sites) in some viral (picornavirus, HCV) and cellular mRNAs recruit ribosomes without the cap. Poliovirus protease cleaves eIF4G, shutting off host cap-dependent translation while the viral IRES still works.
Elongation (the cycle, three steps per residue)
| Step | Bacterial factor | Eukaryotic factor | Energy |
|---|---|---|---|
| 1. Decoding: aa-tRNA delivered to the A site | EF-Tu·GTP (recycled by EF-Ts) | eEF1A·GTP (recycled by eEF1B) | 1 GTP |
| 2. Peptide bond formation: α-amino group of the A-site aa-tRNA attacks the ester carbonyl of the P-site peptidyl-tRNA | 23S rRNA (no factor) | 28S rRNA | None |
| 3. Translocation: mRNA moves 3 nt, tRNAs move A→P→E | EF-G·GTP | eEF2·GTP | 1 GTP |
- The growing chain is transferred onto the incoming tRNA; proteins grow N → C while mRNA is read 5’ → 3’.
- Kinetic proofreading: GTP hydrolysis by EF-Tu happens only after correct codon–anticodon pairing has induced a conformational change in the decoding centre; a near-cognate tRNA usually dissociates before or after hydrolysis.
- E. coli ribosomes add roughly 15–20 amino acids per second.
Termination and recycling
- A stop codon in the A site is recognised by a release factor, a protein that mimics a tRNA:
- Bacteria: RF1 (UAA, UAG), RF2 (UAA, UGA); RF3·GTP removes them.
- Eukaryotes: eRF1 recognises all three stops; eRF3·GTP assists.
- RFs place a conserved GGQ motif in the peptidyl transferase centre so that water is the nucleophile → the peptide is hydrolysed from the P-site tRNA.
- Recycling: bacterial RRF + EF-G·GTP (and IF3) split the ribosome; eukaryotic recycling uses the ATPase ABCE1.
- Rescue: in bacteria, ribosomes stalled at the end of a stop-less mRNA are rescued by tmRNA (SsrA), which acts first as a tRNA (charged with Ala) and then as an mRNA, adding a short C-terminal degradation tag recognised by ClpXP and other proteases (trans-translation).
Energy accounting
| Event | High-energy phosphate bonds |
|---|---|
| Charging each aa-tRNA (ATP → AMP + PPi → 2 Pi) | 2 |
| EF-Tu delivery | 1 (GTP) |
| EF-G translocation | 1 (GTP) |
| Per peptide bond (elongation) | at least 4 |
| Initiation (IF2) and termination (RF3) | 1 each (bacteria); eukaryotic scanning also uses ATP |
Errors corrected by proofreading (by aaRS or EF-Tu) cost extra, so 4 is a minimum.
Polysomes and coupling
Many ribosomes translate one mRNA at once (polysome). In bacteria, transcription and translation are coupled (no nucleus), which is what makes attenuation and Rho polarity possible. In eukaryotes the closed loop (eIF4E–eIF4G–PABP) links the cap and the tail.
Inhibitors of Protein Synthesis
| Inhibitor | Target | Effect | Acts on |
|---|---|---|---|
| Streptomycin (aminoglycoside) | 30S (16S rRNA, S12) | Misreading; at high levels blocks initiation | Bacteria |
| Kanamycin, gentamicin, neomycin | 30S decoding site | Misreading | Bacteria |
| Tetracycline | 30S A site | Blocks aa-tRNA binding | Bacteria (poorly taken up by eukaryotic cells) |
| Chloramphenicol | 50S peptidyl transferase | Blocks peptide bond formation | Bacteria and mitochondria |
| Erythromycin (macrolides) | 50S exit tunnel | Blocks nascent chain exit/translocation early | Bacteria |
| Linezolid | 50S peptidyl transferase centre (A site) | Blocks an early step of translation (classically described as preventing formation of the initiation complex) | Bacteria |
| Fusidic acid | EF-G | Traps EF-G·GDP on the ribosome | Bacteria |
| Kirromycin | EF-Tu | Traps EF-Tu·GDP on the ribosome | Bacteria |
| Thiostrepton | 50S GTPase-associated centre | Blocks factor binding | Bacteria |
| Puromycin | A site of all ribosomes | Aminoacyl-tRNA analogue (resembles the 3’ end of Tyr-tRNA); accepts the peptide → peptidyl-puromycin is released; premature termination | Pro- and eukaryotes |
| Cycloheximide | 60S E site | Blocks translocation | Eukaryotes (not mitochondria) |
| Anisomycin | 60S peptidyl transferase | Blocks peptide bond formation | Eukaryotes |
| Emetine | 40S | Blocks translocation | Eukaryotes |
| Diphtheria toxin | eEF2 | ADP-ribosylates diphthamide (modified His) using NAD⁺; one molecule can kill a cell | Eukaryotes |
| Ricin, Shiga toxin | 28S rRNA | N-glycosidase: removes one specific adenine from the sarcin–ricin loop, blocking factor binding | Eukaryotes |
Regulation of Translation
| Mechanism | How it works | Example |
|---|---|---|
| eIF2α phosphorylation (Ser51) | Phospho-eIF2·GDP binds eIF2B tightly and sequesters it (eIF2B is limiting) → fewer ternary complexes → global inhibition | Kinases: HRI (haem deficiency in erythroid cells), PKR (dsRNA, viral infection; interferon-induced), PERK (ER stress), GCN2 (amino acid starvation, uncharged tRNA) |
| uORF-mediated escape | When ternary complexes are scarce, scanning ribosomes bypass inhibitory uORFs and re-initiate at the main ORF | GCN4 (yeast), ATF4 (mammals) are translated more under eIF2α phosphorylation |
| mTORC1 / 4E-BP | Unphosphorylated 4E-BPs bind eIF4E and block eIF4G binding; mTORC1 phosphorylates 4E-BP (releasing eIF4E) and S6K | Growth factors and amino acids stimulate; rapamycin inhibits mTORC1 |
| IRE–IRP (iron) | Low iron: IRP binds IREs. In the 5’ UTR of ferritin mRNA this blocks translation; in the 3’ UTR of transferrin receptor mRNA it stabilises the mRNA. High iron: IRP1 gains an Fe–S cluster (becomes cytosolic aconitase) and releases; IRP2 is degraded | Iron storage falls, iron uptake rises when iron is low |
| miRNAs | Seed pairing in 3’ UTRs → repression and decay | Hundreds of genes |
| Cytoplasmic polyadenylation | CPEB-regulated lengthening of the poly(A) tail activates stored maternal mRNAs | Oocyte maturation |
| Bacterial mechanisms | SD sequestration by mRNA structure, riboswitches, sRNAs with Hfq, ribosomal protein autoregulation (a free r-protein binds its own mRNA when rRNA is limiting) | |
| Programmed frameshifting | A slippery sequence and a downstream structure shift the frame | RF2 mRNA has an in-frame UGA early; when RF2 is scarce a +1 shift lets full RF2 be made (autoregulation); retroviral −1 shifting makes Gag–Pol |
Post-translational Modifications (PTMs)
| PTM | Residue(s) | Enzyme / site | Function |
|---|---|---|---|
| Phosphorylation | Ser, Thr, Tyr (His, Asp in bacterial two-component systems) | Kinases / phosphatases | Signalling, enzyme regulation |
| Acetylation | N-terminus (most eukaryotic proteins, co-translational); Lys ε-amino | NATs; HATs/KATs and HDACs | Histone and non-histone regulation |
| Methylation | Lys, Arg | SAM-dependent methyltransferases | Chromatin, signalling |
| N-linked glycosylation | Asn in Asn-X-Ser/Thr (X ≠ Pro) | Oligosaccharyltransferase in the ER, transferring Glc₃Man₉GlcNAc₂ from dolichol pyrophosphate; trimmed and remodelled in ER and Golgi | Folding quality control (calnexin/calreticulin), targeting, stability. Tunicamycin blocks the first step of dolichol-oligosaccharide synthesis |
| O-linked glycosylation | Ser, Thr | Golgi glycosyltransferases | Mucins, proteoglycans |
| O-GlcNAc | Ser, Thr of cytosolic and nuclear proteins | OGT / OGA | Nutrient sensing; competes with phosphorylation |
| N-myristoylation | N-terminal Gly (after Met removal) | N-myristoyltransferase, co-translational, irreversible | Membrane association (Src, Gα) |
| Palmitoylation (S-acylation) | Cys | Reversible | Membrane microdomains, cycling |
| Prenylation | Cys of C-terminal CaaX box | Farnesyl or geranylgeranyl transferase; then -aaX cleaved and carboxyl methylated | Membrane anchoring (Ras, lamins) |
| GPI anchor | C-terminus | Transamidase in the ER replaces a C-terminal signal | Outer-leaflet anchoring; released by PI-specific phospholipase C |
| Ubiquitination, SUMOylation | Lys | E1–E2–E3 cascades | Degradation, trafficking, nuclear functions |
| Disulfide bonds | Cys | Protein disulfide isomerase (ER), oxidising environment | Secreted and extracellular proteins |
| Hydroxylation | Pro, Lys in collagen | Prolyl and lysyl hydroxylases (need ascorbate, Fe²⁺, α-ketoglutarate) | Collagen stability (scurvy) |
| γ-Carboxylation | Glu | Vitamin K-dependent carboxylase | Ca²⁺ binding in clotting factors |
| Proteolytic processing | Signal peptidase; prohormone convertases; zymogen activation | Preproinsulin → proinsulin → insulin + C-peptide; trypsinogen → trypsin | |
| ADP-ribosylation | Arg, diphthamide, Cys | Bacterial toxins (cholera on Gαs, pertussis on Gαi, diphtheria on eEF2); PARPs | |
| Protein splicing | Self-excising inteins | Rare; used in biotechnology |
Protein Trafficking
Proteins are sorted by signals in their own sequence. Two routes:
graph TD
R["Cytosolic ribosome"] --> F["Free ribosomes:
cytosol, nucleus (NLS),
mitochondria, chloroplast,
peroxisome (post-translational)"]
R --> E["SRP-bound ribosome on ER:
co-translational import"]
E --> ER["ER lumen or membrane"]
ER --> G["Golgi (COPII forward,
COPI retrieval)"]
G --> P["Plasma membrane /
secretion"]
G --> L["Lysosome
(mannose-6-phosphate)"]
ER -. KDEL retrieval .-> ERCo-translational import into the ER (signal hypothesis)
- An N-terminal signal sequence (a core of roughly 6–12 hydrophobic residues, often preceded by positively charged residues) emerges from the ribosome.
- SRP (signal recognition particle: 7SL RNA + proteins; SRP54 binds the signal) binds it and pauses elongation.
- SRP docks on the SRP receptor in the ER membrane; both are GTPases, and GTP hydrolysis releases SRP.
- The ribosome feeds the chain through the Sec61 translocon (Sec61αβγ); signal peptidase removes the signal in the lumen.
- Membrane proteins: a stop-transfer sequence halts translocation and moves laterally into the bilayer; an internal signal-anchor sequence inserts with either orientation, depending on flanking charges (positive-inside rule). Multi-pass proteins alternate signal-anchor and stop-transfer segments.
Blobel’s work on signal sequences was recognised with the 1999 Nobel Prize in Physiology or Medicine.
ER quality control: BiP (Hsp70) binds unfolded segments; the calnexin/calreticulin cycle uses glucose trimming and re-glucosylation (UGGT) on N-glycans to hold misfolded glycoproteins; terminally misfolded proteins are retro-translocated and degraded by the proteasome (ERAD). Accumulated misfolded protein triggers the unfolded protein response (sensors IRE1, which splices XBP1 mRNA; PERK, which phosphorylates eIF2α; ATF6, which is cleaved in the Golgi).
Sorting signals
| Destination | Signal | Machinery |
|---|---|---|
| ER lumen (resident) | C-terminal KDEL (HDEL in yeast) | KDEL receptor in cis-Golgi retrieves via COPI |
| ER membrane (resident) | C-terminal KKXX | COPI retrieval |
| Lysosome | Mannose-6-phosphate on N-glycans (added in the cis-Golgi by GlcNAc phosphotransferase recognising a signal patch) | M6P receptors in the TGN; clathrin vesicles; receptors released at low pH in endosomes. I-cell disease: phosphotransferase defect, hydrolases secreted |
| Nucleus | NLS: basic, e.g. PKKKRKV (SV40 large T); bipartite (nucleoplasmin) | Importin α/β; Ran-GTP in the nucleus releases cargo (RanGEF/RCC1 nuclear, RanGAP cytoplasmic) |
| Out of the nucleus | Leucine-rich NES | CRM1 (exportin-1) + Ran-GTP |
| Mitochondrial matrix | N-terminal amphipathic α-helix (presequence) with positive charges | TOM (outer), TIM23 (inner; needs membrane potential), mtHsp70 (ATP) pulls; MPP cleaves. TIM22 inserts carrier proteins; SAM inserts β-barrels |
| Chloroplast | N-terminal transit peptide (stroma); a second signal for thylakoid lumen | TOC/TIC |
| Peroxisome matrix | C-terminal SKL (PTS1; receptor Pex5) or N-terminal PTS2 (Pex7) | Imports folded, even oligomeric, proteins; signal not cleaved (PTS1) |
| Plasma membrane / secretion | Default after ER and Golgi (constitutive); regulated secretion via dense-core granules |
Vesicle coats: COPII (ER → Golgi; GTPase Sar1), COPI (Golgi → ER and intra-Golgi; ARF1), clathrin with adaptor proteins (TGN → endosomes; plasma membrane endocytosis; dynamin pinches off). Specific fusion uses Rab GTPases (identity and tethering) and v-SNARE/t-SNARE pairing; NSF (ATPase) and α-SNAP disassemble SNARE complexes after fusion.
Bacteria: the Sec pathway (SecA ATPase pushes unfolded proteins through SecYEG; SecB chaperone), the bacterial SRP (Ffh + 4.5S RNA) for membrane proteins, and the Tat pathway (twin-arginine signal) for folded proteins.
Protein Degradation
The ubiquitin–proteasome system
Ubiquitin is a 76-residue protein attached through its C-terminal Gly to Lys ε-amino groups.
- E1 (ubiquitin-activating) forms a ubiquitin–AMP intermediate then a thioester (uses ATP).
- E2 (conjugating) receives ubiquitin as a thioester.
- E3 (ligase) provides substrate specificity: RING E3s transfer directly from E2; HECT E3s form a thioester intermediate first. Major multi-subunit E3s: SCF (F-box proteins recognise phosphodegrons; G1/S) and APC/C (Cdc20, Cdh1; degrades securin and mitotic cyclins).
- A Lys48-linked chain of at least four ubiquitins targets the protein to the 26S proteasome. (Lys63 chains and monoubiquitination signal DNA repair, kinase activation in NF-κB signalling and endocytosis instead.)
26S proteasome = 20S core + 19S regulatory particle(s)
- 20S core: four stacked rings α₇β₇β₇α₇; three β subunits are active, using an N-terminal Thr nucleophile: β1 caspase-like, β2 trypsin-like, β5 chymotrypsin-like. Bortezomib (multiple myeloma drug) inhibits β5; MG132 and lactacystin are research inhibitors.
- 19S: recognises the chain, removes and recycles ubiquitin (deubiquitinase Rpn11), unfolds the substrate with six AAA-ATPases (ATP) and threads it into the core.
- Products: short peptides (some loaded onto MHC class I after processing by the immunoproteasome).
Hershko, Ciechanover and Rose received the 2004 Nobel Prize in Chemistry for ubiquitin-mediated protein degradation.
Degradation signals
- N-end rule (N-degron): the identity of the N-terminal residue sets the half-life. In yeast, Arg, Lys, His (basic) and Phe, Leu, Trp, Tyr, Ile (bulky hydrophobic) are destabilising; Met, Gly, Ala, Ser, Thr, Val are stabilising. N-recognin E3s (Ubr1) bind destabilising N-termini.
- PEST sequences (rich in Pro, Glu, Ser, Thr) in short-lived proteins.
- Phosphodegrons (IκB, β-catenin via SCFβTrCP), destruction box (cyclins via APC/C), oxygen-dependent hydroxylation (HIF-1α Pro hydroxylation → von Hippel–Lindau E3).
Lysosomal degradation and autophagy
| Route | Cargo | Key players |
|---|---|---|
| Endocytosis | Membrane receptors, extracellular material | Clathrin, early → late endosome → lysosome; monoubiquitin and ESCRT for multivesicular bodies |
| Macroautophagy | Bulk cytoplasm, organelles (mitophagy), aggregates | mTORC1 inhibits the ULK1 complex; nutrient starvation activates it. Atg8/LC3 is lipidated (LC3-I → LC3-II, PE-conjugated) on the autophagosome; p62/SQSTM1 links ubiquitinated cargo; fusion with lysosome |
| Microautophagy | Cytoplasm engulfed directly by the lysosome | |
| Chaperone-mediated autophagy | Soluble proteins with a KFERQ-like motif | Hsc70 delivers to LAMP-2A, which translocates them into the lysosome |
Yoshinori Ohsumi received the 2016 Nobel Prize in Physiology or Medicine for discovering mechanisms of autophagy (yeast atg genes).
Other proteases: calpains (Ca²⁺-activated), caspases (apoptosis, cleave after Asp). Bacteria lack ubiquitin and the 26S proteasome; they use ATP-dependent proteases Lon, ClpXP/ClpAP, FtsH and HslUV (whose HslV resembles proteasome β subunits).
Memory Tricks
Don’t Confuse
| This | vs | That |
|---|---|---|
| Shine–Dalgarno: pairs with 16S rRNA 3’ end | vs | Kozak: context around AUG for scanning ribosomes |
| fMet-tRNAfMet (bacteria, organelles) | vs | Met-tRNAᵢ (eukaryotic cytosol), not formylated |
| EF-Tu: brings aa-tRNA (eEF1A) | vs | EF-G: translocation (eEF2) |
| RF1: UAA, UAG; RF2: UAA, UGA | vs | eRF1: all three stops |
| Chloramphenicol: 50S, also mitochondria | vs | Cycloheximide: 80S only, not mitochondria |
| Diphtheria toxin: modifies eEF2 (protein) | vs | Ricin: depurinates 28S rRNA |
| Ferritin IRE (5’ UTR): IRP binding blocks translation | vs | TfR IRE (3’ UTR): IRP binding stabilises mRNA |
| N-myristoylation: Gly, irreversible, co-translational | vs | Palmitoylation: Cys, reversible |
| K48 chains: proteasome | vs | K63 chains: signalling, repair, endocytosis |
| Proteasome: ubiquitinated proteins, ATP | vs | Lysosome: autophagy and endocytic cargo, acid hydrolases |
| Mitochondrial presequence: cleaved | vs | Peroxisomal SKL: not cleaved; folded import |
Common Mistakes
Practice
All questions below are original practice questions written in CSIR NET style. They are not previous-year questions.
Level 1: Foundation
- Which rRNA contains the anti-Shine–Dalgarno sequence?
- Which elongation factor is ADP-ribosylated by diphtheria toxin?
- Which C-terminal tripeptide targets proteins to the peroxisomal matrix?
Answers
- 16S rRNA (3’ end) of the 30S subunit.
- eEF2 (at diphthamide).
- Ser-Lys-Leu (SKL), PTS1.
Level 2: Part B Style
Q1 (practice). A tRNA with the anticodon 5’-IGC-3’ can read which codons?
- (a) GCU, GCC, GCA
- (b) GCU and GCC only
- (c) CGA, CGG, CGU
- (d) GCG only
Answer and explanation
(a). The anticodon 5’-IGC-3’ pairs antiparallel with codon 5’-GCN-3’: C pairs with G (first codon base), G pairs with C (second), and the wobble I pairs with U, C or A at the third position. So GCU, GCC and GCA (all Ala). It cannot read GCG.
Q2 (practice). In a rabbit reticulocyte lysate, a drug causes polysomes to remain intact and “frozen” on mRNA, whereas a second drug causes rapid release of nascent chains and polysome breakdown. The two drugs are most likely:
- (a) puromycin and cycloheximide
- (b) cycloheximide and puromycin
- (c) tetracycline and chloramphenicol
- (d) streptomycin and puromycin
Answer and explanation
(b). Cycloheximide blocks translocation on 80S ribosomes, so ribosomes stop where they are and polysomes are preserved (it is used to stabilise polysomes for profiling). Puromycin causes premature release of peptidyl-puromycin, so ribosomes fall off. Tetracycline, chloramphenicol and streptomycin are bacterial-ribosome drugs.
Q3 (practice). A lysosomal hydrolase is found in the culture medium instead of in lysosomes of a patient’s fibroblasts. The most likely defect is in:
- (a) the KDEL receptor
- (b) N-acetylglucosamine phosphotransferase in the cis-Golgi
- (c) signal recognition particle
- (d) importin α
Answer and explanation
(b). Without the phosphotransferase, no mannose-6-phosphate is made; hydrolases are not captured by M6P receptors in the TGN and follow the default secretory route (I-cell disease). An SRP defect would prevent entry to the ER at all.
Q4 (practice). Which change will increase ferritin synthesis in a cell?
- (a) Iron deficiency
- (b) Iron loading, which converts IRP1 into aconitase
- (c) Deleting the iron-responsive element from the transferrin receptor mRNA
- (d) Over-expression of IRP2 that cannot be degraded
Answer and explanation
(b). In iron excess, IRP1 acquires its Fe–S cluster and leaves the ferritin 5’ IRE, so ferritin mRNA is translated. Iron deficiency (a) and stable IRP2 (d) keep the IRE occupied and repress ferritin. (c) affects TfR mRNA stability, not ferritin translation.
Level 3: Part C Style
Q1 (practice). A bacterial protein of 300 amino acids (including the initiating fMet) is translated at 15 residues per second. (i) What is the minimum number of high-energy phosphate bonds used for the elongation phase only, i.e. to charge and add residues 2–300 (ignore formylation, initiation, termination and proofreading)? (ii) How long does one ribosome take to synthesise the chain? (iii) If ribosomes initiate on the mRNA every 2 s, how many ribosomes are on the mRNA at steady state?
Answer and worked solution
(i) 299 peptide bonds. Each needs 2 (charging) + 1 (EF-Tu) + 1 (EF-G) = 4 high-energy bonds: \(299 \times 4 = 1196\).
(ii) \(t = 300/15 = 20\ \text{s}\).
(iii) Residence time / initiation interval = 20/2 = 10 ribosomes in the polysome.
Q2 (practice). Cells are pulse-labelled with ³⁵S-Met for 10 min and chased with excess unlabelled Met. A protein X is immunoprecipitated at each time and the labelled band quantified:
| Chase (h) | 0 | 1 | 2 | 3 | 4 |
|---|---|---|---|---|---|
| X, control | 100 | 71 | 50 | 35 | 25 |
| X + bortezomib | 100 | 97 | 94 | 91 | 89 |
| X + chloroquine (lysosome inhibitor) | 100 | 70 | 51 | 36 | 24 |
Which statements are correct?
(A) The half-life of X in control cells is about 2 h. (B) X is degraded mainly by the proteasome. (C) X is likely to carry K48-linked polyubiquitin before degradation. (D) X is degraded mainly by chaperone-mediated autophagy.
- (a) A, B and C
- (b) A and D only
- (c) B and C only
- (d) A, B, C and D
Answer and worked solution
(a) A, B and C.
- 100 → 50 in 2 h and 50 → 25 in the next 2 h: first-order decay, \(t_{1/2} = 2\) h, \(k = 0.693/2 = 0.35\ \text{h}^{-1}\) (A).
- Bortezomib (β5 inhibitor) almost abolishes degradation, chloroquine (raises lysosomal pH) has no effect: proteasomal (B), and therefore usually K48-ubiquitin-dependent (C).
- (D) is contradicted by the lack of chloroquine effect.
Q3 (practice). Fusion-protein experiments: (1) The N-terminal 25 residues of a mitochondrial matrix protein fused to cytosolic GFP send GFP to the matrix, and the 25 residues are cleaved. (2) Adding the uncoupler FCCP to the cells blocks import of the fusion. (3) GFP fused at its C-terminus to -SKL appears in peroxisomes even when GFP is first allowed to fold. (4) A secreted protein whose signal sequence is deleted stays in the cytosol. Explain each result.
Answer and worked solution
- The presequence is necessary and sufficient for matrix targeting; MPP removes it after import.
- Movement of the positively charged presequence through TIM23 requires the membrane potential (negative inside); FCCP collapses it, so import stops (TOM binding can still occur).
- PTS1 (SKL) is recognised by Pex5; peroxisomes import folded proteins, unlike mitochondria, which need unfolded precursors.
- Without a signal sequence, SRP cannot bind, so the protein is made on free ribosomes and stays in the cytosol: the default for proteins without a signal.
Quick Revision Table
| Item | Fact |
|---|---|
| Code | 61 sense + 3 stop (UAA, UAG, UGA); mito UGA = Trp |
| Wobble | Anticodon position 34; G·U; I pairs with U, C, A; minimum about 32 tRNAs |
| Charging | aa + ATP → aa-AMP + PPi → aa-tRNA; 2 ~P; class I 2’-OH, class II 3’-OH |
| Accuracy | aaRS editing sites; error ~10⁻⁴ per residue |
| Ribosomes | 70S = 30S (16S) + 50S (23S, 5S); 80S = 40S (18S) + 60S (28S, 5.8S, 5S) |
| Peptidyl transferase | Large-subunit rRNA (ribozyme) |
| Bacterial initiation | SD–anti-SD; IF1, IF2·GTP, IF3; fMet from N¹⁰-formyl-THF |
| Eukaryotic initiation | eIF4F on cap, 43S scanning, Kozak (A at −3, G at +4), eIF2·GTP·Met-tRNAᵢ, eIF2B GEF, eIF5B |
| Elongation | EF-Tu/eEF1A (decoding), rRNA (peptide bond), EF-G/eEF2 (translocation); ≥4 ~P per bond |
| Termination | RF1 (UAA, UAG), RF2 (UAA, UGA), RF3; eRF1 + eRF3; GGQ; tmRNA rescue |
| Inhibitors | Strep (30S misreading), Tet (A site), Cam (50S PTC, mito), Ery (tunnel), puromycin (all), cycloheximide (80S), DT (eEF2), ricin (28S) |
| Control | eIF2α-P (HRI, PKR, PERK, GCN2) → ATF4/GCN4 up; mTORC1–4E-BP; IRE/IRP; RF2 frameshift |
| N-glycosylation | Asn-X-Ser/Thr; OST in ER; dolichol-PP; tunicamycin |
| Lipid anchors | Myristoyl (N-Gly), palmitoyl (Cys), prenyl (CaaX), GPI |
| ER targeting | Signal → SRP (7SL RNA, SRP54) → SR → Sec61; signal peptidase |
| Signals | KDEL (ER), M6P (lysosome), NLS/importin/Ran, NES/CRM1, presequence/TOM-TIM, SKL/Pex5, transit peptide/TOC-TIC |
| Coats | COPII (ER → Golgi, Sar1); COPI (retrograde, ARF1); clathrin (TGN, endocytosis) |
| UPR | IRE1 (XBP1 splicing), PERK (eIF2α), ATF6 |
| Ubiquitin | 76 aa; E1 (ATP) → E2 → E3 (RING, HECT; SCF, APC/C); K48 → proteasome |
| Proteasome | 26S = 20S (α₇β₇β₇α₇; β1, β2, β5; Thr) + 19S; bortezomib |
| Autophagy | mTORC1 ⊣ ULK1; LC3-II; p62; CMA via KFERQ, Hsc70, LAMP-2A |
Key Takeaways
What’s Next
- Regulation of Gene Expression and Epigenetics — attenuation needs the coupled translation described here.
- Transcription, RNA Processing and Non-coding RNA — revisit miRNAs and NMD as links between RNA processing and translation.
- Enzymes: Catalysis, Kinetics and Regulation — zymogens and covalent modification as enzyme control.
- Quick Revision — the whole unit on one page.